Effect of High Dose Insulin on Infectious Complications Following Major Surgery

NARecruitingINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Surgical Site Infection After Major Surgery
Interventions
OTHER

Hyperinsulinemic normoglycemic clamp

Patients will receive an IV infusion of 2 mU/kg/min (0.12 U/kg/hour) starting in the operating room. Dextrose 20% will be titrated to maintain blood glucose between 4 and 6 mmol/l. At the end of surgery, the insulin infusion will be stopped and the dextrose infusion weaned off in the postanesthesia care unit.

OTHER

Standard glucose management

Blood glucose levels will be treated by a standard insulin sliding scale.

Trial Locations (3)

8380456

NOT_YET_RECRUITING

Hospital Clinico Universidad de Chile, Independencia

H3A 1A1

RECRUITING

Royal Victoria Hospital, McGill University Health Centre, Montreal

H3A1A1

NOT_YET_RECRUITING

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER